Monsanto Company (MON) has reported a 28.69 percent rise in profit for the quarter ended Feb. 28, 2017. The company has earned $1,368 million, or $3.09 a share in the quarter, compared with $1,063 million, or $2.41 a share for the same period last year. On the other hand, adjusted net income for the quarter stood at $1,409 million, or $3.19 a share compared with $1,068 million or $2.42 a share, a year ago. Revenue during the quarter grew 11.96 percent to $5,074 million from $4,532 million in the previous year period. Gross margin for the quarter expanded 85 basis points over the previous year period to 58.18 percent. Total expenses were 63.26 percent of quarterly revenues, down from 63.31 percent for the same period last year. This has led to an improvement of 4 basis points in operating margin to 36.74 percent.
Operating income for the quarter was $1,864 million, compared with $1,663 million in the previous year period.
"We are delighted to have delivered such an excellent first half and strong second quarter, in the face of what is still a tough macro economy for agriculture," said Hugh Grant, Monsanto chairman and chief executive officer. "While we're increasing confidence in the outlook for the rest of the year, our emphasis at Monsanto is where it has always been on bringing innovation to growers. Our proven innovation and unique platform advantages position us well to meet the challenges ahead, as well as make us an attractive, complementary partner for Bayer."
For fiscal year 2017, Monsanto Company expects diluted earnings per share to be in the range of $3.95 to $4.44. It expects diluted earnings per share to be in the range of $4.50 to $4.90 on adjusted basis for the same period.
Operating cash flow improves
Monsanto Company has generated cash of $1,537 million from operating activities during the first half, up 10.66 percent or $148 million, when compared with the last year period. The company has spent $438 million cash to meet investing activities during the first six months as against cash outgo of $483 million in the last year period.
The company has spent $494 million cash to carry out financing activities during the first six months as against cash outgo of $3,502 million in the last year period.
Cash and cash equivalents stood at $2,281 million as on Feb. 28, 2017, up 117.24 percent or $1,231 million from $1,050 million on Feb. 29, 2016.
Working capital increases marginally
Monsanto Company has recorded an increase in the working capital over the last year. It stood at $2,593 million as at Feb. 28, 2017, up 1.93 percent or $49 million from $2,544 million on Feb. 29, 2016. Current ratio was at 1.36 as on Feb. 28, 2017, down from 1.43 on Feb. 29, 2016.
Cash conversion cycle (CCC) has decreased to 100 days for the quarter from 201 days for the last year period. Days sales outstanding were almost stable at 57 days for the quarter, when compared with the last year period.
Days inventory outstanding has decreased to 77 days for the quarter compared with 178 days for the previous year period. At the same time, days payable outstanding was almost stable at 34 days for the quarter, when compared with the previous year period.
Debt moves up marginally
Monsanto Company has witnessed an increase in total debt over the last one year. It stood at $9,171 million as on Feb. 28, 2017, up 1.58 percent or $143 million from $9,028 million on Feb. 29, 2016. Total debt was 42.91 percent of total assets as on Feb. 28, 2017, compared with 46.50 percent on Feb. 29, 2016. Debt to equity ratio was at 1.65 as on Feb. 28, 2017, down from 2.17 as on Feb. 29, 2016. Interest coverage ratio improved to 18.27 for the quarter from 16.15 for the same period last year.
Disclaimer: Please note that this is an auto-generated article. IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website. For queries contact: [email protected]
